Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2014, Vol. 41 Issue (5): 534-536    DOI: 10.12891/ceog17382014
Original Research Previous articles | Next articles
Maternal serum pregnancy-associated plasma protein-A levels in hyperemesis gravidarum: a prospective case control study
B.S. Unlu1, *(), H. Energin1, Y. Yildiz1, E. Unlu1, E.G. Yapar Eyi1
1Dr. Zekai Tahir Burak Women’s Health Education and Research Hospital, Department of Perinatology, Ankara (Turkey)
Download:  PDF(57KB)  ( 9 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose: To investigate if maternal serum pregnancy-associated plasma protein-A levels are affected in hyperemesis gravidarum (HG). Materials and Methods: A prospective case control study was conducted in 169 HG cases who had one or more antepartum hospitilization for HG. The control pregnancies were 132 and were selected randomly among all women who had first trimester prenatal screening in antenatal outpatient clinic between 2011 and 2012. Results: Maternal serum pregnancy-associated plasma protein-A levels were significantly higher in hyperemesis gravidarum group compared with control group (p = 0.002 p < 0.05 95% CI). Power analysis of independent sample t-test, two-sided, for pregnancy-associated plasma protein-A was 0.88. Maternal serum free β-human chorionic gonadotropin values were not different between two groups (p > 0.05). Conclusion: Increased pregnancy-associated plasma protein- A levels associated with HG, even after excluding potential cofounders.
Key words:  Pregnancy-associated plasma protein-A (PAPP-A)      Hyperemesis gravidarum      Human chorionic gonadotropin (hCG)     
Published:  10 October 2014     
*Corresponding Author(s):  B.S. UNLU     E-mail:  drserdarunlu@yahoo.com

Cite this article: 

B.S. Unlu, H. Energin, Y. Yildiz, E. Unlu, E.G. Yapar Eyi. Maternal serum pregnancy-associated plasma protein-A levels in hyperemesis gravidarum: a prospective case control study. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(5): 534-536.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog17382014     OR     https://ceog.imrpress.com/EN/Y2014/V41/I5/534

[1] G. Keren, G. Ayala. Factors associated with hyperemesis gravidarum[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 391-395.
[2] Z.O. Dag, O.B. Tulmac, Y. Isik, U. Kisa, S. Aydin. Changes in serum adropin, salusin alpha and salusin beta, vaspin, and preptin in hyperemesis gravidarum[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 68-71.
[3] E.C. Kavak, S.B. Kavak, R. Ilhan, S. Kaplan, H. Bagci, M. Kaya. Changes in irisin levels in patients with hyperemesis gravidarum[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(2): 200-202.
[4] Z.M. Pirimoglu, K. Guzelmeric, B. Alpay, O. Balcik, O. Unal, M.C. Turan. Psychological factors of hyperemesis gravidarum by using the SCL-90-R questionnaire[J]. Clinical and Experimental Obstetrics & Gynecology, 2010, 37(1): 56-59.
No Suggested Reading articles found!